i believe NFLD is on track to be the first company in the "blood substitute" arena to get full approval. It's a fascinating area and all of the players seem to be active on one level or another: sybd bpur & even allp if i recall
but the class act is NFLD and i am looking forward to listening to the cc call.
Providing stable oxygen-carrying blood sub for trauma on the battlefield will be a big gain for someone. Military contracts could be huge and longer term players might consider spreading their bets....BPUR, has had some ongoing work with the military, and i don't know if lack of FDA approval means anything to the military.
do your own DD here pls...just going from admittedly gap filled memory here
TRADING: "More Signal...less Noise"
LIVING: "One World, One Family, Warm Heart" Dalai Lama
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.